Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 12.3.2018 | EN | Official Journal of the European Union | C 94/17 |

---

Judgment of the General Court of 31 January 2018 — Novartis AG v EUIPO — SK Chemicals (Figurative EU trade mark representing a transdermal patch)

(Case T-44/16)[(1)](#ntr1-C_2018094EN.01001702-E0001)

((EU trade mark - Invalidity proceedings - Figurative EU trade mark representing a transdermal patch - Absolute ground for refusal - Sign consisting exclusively of the shape of the product necessary to obtain a technical result - Article 7(1)(e)(ii) of Regulation (EC) No 207/2009 (now Article 7(1)(e)(ii) of Regulation (EU) 2017/1001)))

(2018/C 094/21)

Language of the case: English

Parties

Applicant: Novartis AG (Basle, Switzerland) (represented: initially by M.R. Douglas, and subsequently by A. Nordemann-Schiffel, lawyers)

Defendant: European Union Intellectual Property Office (represented by: H. Kunz, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO intervening before the General Court: SK Chemicals GmbH (Eschborn, Germany) (represented by: R. Dissmann, J. Bogatz, and C. Lindenthal, lawyers)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 27 November 2015 (Case R 2342/2014-5), relating to invalidity proceedings between SK Chemicals and Novartis.

Operative part of the order

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Novartis AG to pay the costs. |

---

[Top](#document1)